Kiyo Tanaka

5PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 29, 2026
Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017.

|May 16, 2026
Primary tumour resection reduces the risk of major local morbidity in de novo stage IV breast cancer: secondary data analysis from the JCOG1017 randomized clinical trial.

|Apr 16, 2026
Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017.

|Dec 11, 2023
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale.

Yosuke Aoyama, Eri Hoshino, Akihiko Shimomura

|Feb 18, 2021
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.

Kiyo Tanaka, Norikazu Masuda, Naoki Hayashi

Pageof 1

Frequent Collaborators

1 joint publications

Yosuke Aoyama

1 joint publications

Eri Hoshino

1 joint publications

Akihiko Shimomura

1 joint publications

Chikako Shimizu